Back to search

Democritus University of Thrace (DUTH)

Η συμβολή της εισπνευστικής συσκευής, του φαρμάκου και της φαρμακοτεχνικής μορφής αυτού στην επιτυχία της αγωγής του ασθενούς με αποφρακτικό νόσημα των αεραγωγών

Abstract

dc:description

Introduction Obstructive airway diseases, Chronic Obstructive Pulmonary Disease (COPD) and Asthma, are increasing in frequency throughout the world, having a significant impact on quality of life. Compliance plays a major role in disease outcome, as it has been associated with increased morbidity and mortality. A better understanding of the factors associated with adherence, can lead to more appropriate decisions regarding management.MethodsWe surveyed physicians’ perspective on the impact of device and substance characteristics on patients’ compliance. This study was carried out by running a structured questionnaire, to a total of 144 physicians, conducting personal interviews and evaluating answers on a scale from 1 for most to 6 for least important influencing parameter, during a national Respiratory Congress. Evaluated parameters included rapid onset of action, duration of action, ease of use, low flow resistance, ability of the device to confirm the dose, type of inhalation device, and the formulation of the drug. Participants were asked to determine the importance of the above-mentioned parameters in chronic obstructive lung diseases in general and subsequently in COPD and asthma separately. ResultsOn average “Rapid onset of action” was ranked lower (more important- influential) than all the other parameters. It was statistically significantly lower than all other parameters except that of “Type of inhalation device”. On the contrary, “Adverse events” was ranked statistically significantly higher (less important- influential) than all the other parameters.In more detailed analysis, in patients with Asthma, “Rapid onset of action” was ranked statistically significantly lower (more important-influential) than all the other parameters. The next most influential parameters were “Ease of use” and “Duration of action” that were ranked statistically significantly lower (more important- influential) than the other 4 parameters. On the contrary, “The formulation of the drug” was ranked statistically significantly higher (less important) than all other parameters. While in patients with COPD, “Rapid onset of action”, “Duration of action” and “Ease of use” were ranked statistically significantly lower (more important-influential) than the other four parameters. The parameter “formulation of the drug” was ranked statistically significantly higher (less important) than all other parameters, except that of “Ability of the device to confirm the dose”. In comparison of parameters influencing the compliance between patients with COPD and asthma , the following parameters were differentiated in the comparison between patients with Asthma and COPD patients,: Rapid onset of action was ranked statistically significantly lower (more important-influential) in Asthmatic patients, Low flow resistance was ranked statistically significantly higher (less important-influential) in Asthmatic patients, duration of action and ease of use were marginally statistically significantly higher (less important-influential) in Asthmatic patients .DiscussionIn this study surveying the opinion of physicians treating patients with chronic obstructive airways diseases (asthma and COPD), rapid onset of action, ease of use and duration of action were the most important parameters favoring patients’ compliance for both diseases.As expected, rapid onset of action was the most important factor influencing compliance both in COPD and asthma. Interestingly, it was statistically more important in asthma than in COPD. This finding reflects the difference in pathophysiology and clinical behavior between asthma in COPD as perceived by physicians. In general, asthma is considered a disease which is more likely to be complicated with episodes of acute shortness of breath in need of immediate relief. Duration of action was also considered as an important parameter influencing compliance, irrespective of the underlying diagnosis. This parameter was numerically more important in COPD compared to asthma. Duration of action is clinically relevant for bronchodilators as their duration of action has a direct impact on patients’ symptoms and therefore compliance. The above physicians views also correlate with patients’ perspectives.11 The fact that adverse events were not considered at all as an important compliance factor, confirms the strong belief of physicians in the safety of inhaled medications. Ease of use was also considered as a key factor for compliance. In asthma ease of use is especially important during an acute event of dyspnea needing immediate relief. In COPD patients, who are usually older with several comorbidities ease of use is also an understandable parameter that can affect compliance.The increased number of inhaler devices in recent years has resulted in a confusing number of choices for physicians and patients. The selection of an inhalation device for patients with asthma and COPD has become a complicated issue as several parameters should be taken into account, such as: device/drug availability, clinical setting, patient age, the ability to use the selected device correctly, device use with multiple medications, cost and reimbursement, drug administration time, convenience in both outpatient and inpatient settings, and physician and patient preference. Unfortunately, such studies are scarce in the literature. Strengths of this study are the detailed questionnaire, and the relatively high number of respondents. However, we acknowledge certain limitations of the study. First, we recognize that we explored a complex issue which is difficult to approach by "one- shot strong and direct answers” as the answers do not consider the individualization of the patient path, the level of functional severity, the different phenotypes, the age of the patient and the patient's history. Another limitation is that this study exclusively included specialists and lacks the views of general practitioners. Thus, the results cannot be generalized for non-specialists. Furthermore, the study reflects the beliefs of the physicians of a single country and comparative studies among different countries could provide significant insights. Given the limited number of relevant studies, the present work adds to our understanding of physicians’ perspectives on patient compliance.ConclusionIn conclusion, rapid onset of action, ease of use and duration of action, were classified higher among the parameters examined. Further studies are needed among physicians of different specialties and nationalities to identify more rigorously factors increasing patient compliance. Evidence-based guidelines for the selection of the appropriate inhalation device in specific clinical settings are needed.

Degree

thesis:*
Grantor dc:publisher
Democritus University of Thrace (DUTH)
Year dc:date
2021

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Theodorakis, Stavros
  • Θεοδωράκης, Σταύρος

Subjects

dc:subject × 12

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/49399

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Theodorakis, Stavros; Θεοδωράκης, Σταύρος. Η συμβολή της εισπνευστικής συσκευής, του φαρμάκου και της φαρμακοτεχνικής μορφής αυτού στην επιτυχία της αγωγής του ασθενούς με αποφρακτικό νόσημα των αεραγωγών. Democritus University of Thrace (DUTH), 2021. http://hdl.handle.net/10442/hedi/49399